GABAPENTIN

Granules Pharmaceuticals Inc🇺🇸 United States

FDA Page

Effective Date: Jun 17, 2026
Approval ID: c681c804-c6f3-d63b-e053-2995a90a6b8f
Products: 3 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

GABAPENTIN capsules These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993

Quick Stats

Total Products3

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.